Literature DB >> 1269132

Myocardial ischemia due to infrarenal aortic cross-clamping during aortic surgery in patients with severe coronary artery disease.

R R Attia, J D Murphy, M Snider, D G Lappas, R C Darling, E Lowenstein.   

Abstract

Hemodynamic measurements were performed and ECG recorded before and shortly after infrarenal aortic cross-clamping during operation for abdominal aortic aneurysm in five patients without evidence of heart disease (group I) and in ten patients with severe coronary artery disease (group II). All patients sustained an increase in systemic arterial pressure. Group I demonstrated a decrease in pulmonary artery, pulmonary capillary wedge (PCW), and central venous pressures when the aorta was clamped, whereas group II demonstrated an increase. The difference in response of the groups is significant (P less than 0.05). All three patients who responded to cross-clamping with increases of 7 mm Hg or greater in PCW demonstrated myocardial ischemia during cross-clamping. None of the values measured prior to cross-clamping predicted with certainty the response to cross-clamping. Sodium nitroprusside reversed the elevation of left ventricular filling pressure in all three patients, and in two patients, relieved evidence of myocardial ischemia concurrently. In the third patient, ventricular irritability was abolished by lidocaine and did not recur. We conclude that infrarenal aortic cross-clamping may cause myocardial ischemia in patients with severe coronary artery disease. This ischemia may be predicted by a rise in PCW at the time of cross-clamping, and vasodilator therapy is indicated in such patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269132     DOI: 10.1161/01.cir.53.6.961

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

Review 1.  Perioperative care of the vascular surgery patient: the perspective of the internist.

Authors:  R Granieri; D S Macpherson
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

Review 2.  European Society of Intensive Care Medicine. Expert panel: the use of the pulmonary artery catheter.

Authors: 
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 3.  Anaesthesia for abdominal aortic surgery--a review (Part I).

Authors:  A J Cunningham
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

4.  Anaesthetic management of baboons undergoing heterotopic porcine cardiac xenotransplantation.

Authors:  D Santerre; R H Chen; A Kadner; D Lee-Parritz; D H Adams
Journal:  Vet Res Commun       Date:  2001-05       Impact factor: 2.459

5.  Dipyridamole-thallium myocardial scanning in the preoperative assessment of patients undergoing abdominal aortic aneurysmectomy.

Authors:  R P Grant; C Morgan; M S Page; D N Malm; V Huckel; L C Jenkins
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

6.  Results from coronary artery bypass surgery combined abdominal aortic aneurysm repair.

Authors:  K Kawachi; S Kitamura; S Taniguchi; T Kawata; S Kobayashi; Y Hamada; N Tabayashi; T Nakata; T Yamamoto; Y Kashu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-04

7.  Intravenous nitroglycerin administration during infrarenal aortic clamping.

Authors:  D G Bjoraker; P R Knight
Journal:  Can Anaesth Soc J       Date:  1984-01

8.  Anaesthetic considerations in percutaneous radiofrequency coagulation of the Gasserian ganglion.

Authors:  M Abou-Madi; D Trop; L Morin; A Olivier
Journal:  Can Anaesth Soc J       Date:  1984-05

9.  [Intraoperative nitroglycerin: value of determining individual doses: (surgery of the abdominal aorta)].

Authors:  P Combes; J F Payen; M Durand; J L Magne; Y Pra
Journal:  Can J Anaesth       Date:  1989-11       Impact factor: 5.063

10.  Temporary incomplete ischemia of the legs induced by aortic clamping in man: effects on central hemodynamics and skeletal muscle metabolism by adrenergic block.

Authors:  B Eklöf; P Neglén; D Thomson
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.